Rodrigo Borrega

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Systematic Review

Juvenile Idiopathic Arthritis

Health Information

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Robert W Cross, Megan L Heinrich, Karla A Fenton, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Courtney Woolsey, Daniel J Deer, Natalie S Dobias, Megan M Rowland, Raju Lathigra, Rodrigo Borrega, Joan B Geisbert, Robert F Garry, Luis M Branco, Thomas W Geisbert
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus. Proceedings of the National Academy of Sciences of the United States of America 120 (34) (2023)
Rodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, Nell G Bond, Megan L Heinrich, Megan M Rowland, Raju Lathigra, Duane J Bush, Irina Aimukanova, Whitney N Phinney, Sophia A Koval, Andrew R Hoffmann, Allison R Smither, Antoinette R Bell-Kareem, Lilia I Melnik, Kaylynn J Genemaras, Karissa Chao, Patricia Snarski, Alexandra B Melton, Jaikin E Harrell, Ashley A Smira, Debra H Elliott, Julie A Rouelle, Gilberto Sabino-Santos, Arnaud C Drouin, Mambu Momoh, John Demby Sandi, Augustine Goba, Robert J Samuels, Lansana Kanneh, Michael Gbakie, Zoe L Branco, Jeffrey G Shaffer, John S Schieffelin, James E Robinson, Dahlene N Fusco, Pardis C Sabeti, Kristian G Andersen, Donald S Grant, Matthew L Boisen, Luis M Branco, Robert F Garry
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans. Viruses 13 (11) (2021)
Rodrigo Borrega, Carlos Araújo, Nádia Aguiam, Fernando Magro, João Eurico Fonseca, Silvio Danese, João Almeida Lopes, Joao Goncalves
Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (1) (2021)
Rodrigo Borrega, Joao Paulo Cruz, Peter Taylor, Joao Goncalves
Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (6) (2020)
Rodrigo Borrega, Joao Paulo Cruz, Peter Taylor, Joao Goncalves
Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 33 (6) (2020)